Chemical formula: C₂₁H₂₅NO Molecular mass: 307.429 g/mol PubChem compound: 1201549
Benzatropine possesses both anticholinergic and antihistaminic effects, although only the former have been established as therapeutically significant in the management of parkinsonism.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N04AC01 | Benzatropine | N Nervous system → N04 Anti-parkinson drugs → N04A Anticholinergic agents → N04AC Ethers of tropine or tropine derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| COGENTIN Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Benzatropine is an active ingredient of these brands:
United States (US)
Australia (AU)
New Zealand (NZ)
Singapore (SG)
Turkey (TR)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
